Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: A review and update

Human Pathology

Volumn 45, Issue 2, 2014, Pages 191-205

  Ordóñez, Nelson G ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Immunohistochemistry; KBA.62; Melan A; Melanoma; Microphthalmia transcription factor; PNL2; SOX10; Tyrosinase

Indexed keywords

CD146 ANTIGEN; INTERFERON REGULATORY FACTOR 4; MELAN A; MELANOCORTIN 1 RECEPTOR; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HMB 45; MONOCLONAL ANTIBODY HMB 50; MONOCLONAL ANTIBODY KBA.62; MONOCLONAL ANTIBODY NKI/BETEB; MONOCLONAL ANTIBODY NKI/C3; MONOCLONAL ANTIBODY PNL2; MONOPHENOL MONOOXYGENASE; NEUROTROPHIN RECEPTOR P75; PROTEIN S 100; TRANSCRIPTION FACTOR SOX10; UNCLASSIFIED DRUG;

ARTICLE; CANCER DIAGNOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; MELANOMA; NONHUMAN;

IMMUNOHISTOCHEMISTRY; KBA.62; MELAN A; MELANOMA; MICROPHTHALMIA TRANSCRIPTION FACTOR; PNL2; SOX10; TYROSINASE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD146; ANTIGENS, CD63; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON REGULATORY FACTORS; MART-1 ANTIGEN; MELANOCYTES; MELANOMA; MELANOMA-SPECIFIC ANTIGENS; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; NERVE TISSUE PROTEINS; RECEPTOR, MELANOCORTIN, TYPE 1; RECEPTORS, NERVE GROWTH FACTOR; S100 PROTEINS; SOXE TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84892792122     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.02.007     Document Type: Article

References (181)

1. V.A. LiVolsi, J.J. Brooks, R. Soslow, B.L. Johnson, and D.E. Elder Signet cell melanocytic lesions Mod Pathol 5 1992 515 520
2. M. Auger, N.P. Caraway, E.V. Wojcik, and N.G. Ordóñez Fine needle aspiration biopsy of metastatic myxoid melanoma Cytopathology 5 1994 118 122
3. E.S. Chang, M.R. Wick, P.E. Swanson, and L.P. Dehner Metastatic malignant melanoma with "rhabdoid" features Am J Clin Pathol 102 1994 426 431
4. S.S. Banerjee, and M. Harris Morphological and immunophenotypic variations in malignant melanoma Histopathology 36 2000 387 402
5. G.J. Kontochristopoulos, P.G. Stavropoulos, K. Krasagakis, S. Goerdt, and C.C. Zouboulis Differentiation between merkel cell carcinoma and malignant melanoma: an immunohistochemical study Dermatology 201 2000 123 126
6. B.W. Moore A soluble protein characteristic of the nervous system Biochem Biophys Res Commun 19 1965 739 744
7. T. Isobe, and T. Okuyama The amino-acid sequence of S-100 protein (PAP I-b protein) and its relation to the calcium-binding proteins Eur J Biochem 89 1978 379 388
8. T. Isobe, and T. Okuyama The amino-acid sequence of the alpha subunit in bovine brain S-100a protein Eur J Biochem 116 1981 79 86
9. G.M. Kraehn, M. Schartl, and R.U. Peter Human malignant melanoma. A genetic disease? Cancer 75 1995 1228 1237
10. C.W. Heizmann, G. Fritz, and B.W. Schäfer S100 proteins: structure, functions and pathology Front Biosci 7 2002 d1356 d1368
11. I. Salama, P.S. Malone, F. Mihaimeed, and J.L. Jones A review of the S100 proteins in cancer Eur J Surg Oncol 34 2008 357 364
12. D.B. Zimmer, P. Wright Sadosky, and D.J. Weber Molecular mechanisms of S100-target protein interactions Microsc Res Tech 60 2003 552 559
13. C.W. Heizmann S100B protein in clinical diagnostics: assay specificity Clin Chem 50 2004 249 251
14. L. Santamaria-Kisiel, A.C. Rintala-Dempsey, and G.S. Shaw Calcium-dependent and -independent interactions of the S100 protein family Biochem J 396 2006 201 214
15. F. Sedaghat, and A. Notopoulos S100 protein family and its application in clinical practice Hippokratia 12 2008 198 204
16. E.D. Emberley, Y. Niu, and E. Leygue et al. Psoriasin interacts with Jab1 and influences breast cancer progression Cancer Res 63 2003 1954 1961
17. H.L. Hsieh, B.W. Schäfer, N. Sasaki, and C.W. Heizmann Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays Biochem Biophys Res Commun 307 2003 375 381
18. J. Tímár, N. Udvarhelyi, T. Bánfalvi, K. Gilde, and Z. Orosz Accuracy of the determination of S100B protein expression in malignant melanoma using polyclonal or monoclonal antibodies Histopathology 44 2004 180 184
19. R. Donato, G. Sorci, and F. Riuzzi et al. S100B's double life: intracellular regulator and extracellular signal Biochim Biophys Acta 1793 2009 1008 1022
20. R. Donato S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles Int J Biochem Cell Biol 33 2001 637 668
21. R. Gaynor, R. Irie, D. Morton, and H.R. Herschman S100 protein is present in cultured human malignant melanomas Nature 286 1980 400 401
22. R. Gaynor, H.R. Herschman, R. Irie, P. Jones, D. Morton, and A. Cochran S100 protein: a marker for human malignant melanomas? Lancet 1 1981 869 871
23. T. Nakajima, S. Watanabe, Y. Sato, T. Kameya, Y. Shimosato, and K. Ishihara Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus, and its diagnostic application Cancer 50 1982 912 918
24. J. Palazzo, and P.H. Duray Typical, dysplastic, congenital, and Spitz nevi: a comparative immunohistochemical study Hum Pathol 20 1989 341 346
25. W. Thomson, and R.M. MacKie Comparison of five antimelanoma antibodies for identification of melanocytic cells on tissue sections in routine dermatopathology J Am Acad Dermatol 21 1989 1280 1284
26. H. Yaziji, and A.M. Gown Immunohistochemical markers of melanocytic tumors Int J Surg Pathol 11 2003 11 15
27. M. Miettinen, M. Fernandez, K. Franssila, Z. Gatalica, J. Lasota, and M. Sarlomo-Rikala Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers Am J Surg Pathol 25 2001 205 211
28. S.R. Granter, K.N. Weilbaecher, C. Quigley, and D.E. Fisher Role for microphthalmia transcription factor in the diagnosis of metastatic malignant melanoma Appl Immunohistochem Mol Morphol 10 2002 47 51
29. N.A. Gajjar, A.J. Cochran, and S.W. Binder Is MAGE-1 expression in metastatic malignant melanomas really helpful? Am J Surg Pathol 28 2004 883 888
30. D. Nonaka, L. Chiriboga, and B.P. Rubin Sox10: a pan-schwannian and melanocytic marker Am J Surg Pathol 32 2008 1291 1298
31. S.J. Ohsie, G.P. Sarantopoulos, A.J. Cochran, and S.W. Binder Immunohistochemical characteristics of melanoma J Cutan Pathol 35 2008 433 444
32. K.J. Busam, K. Iversen, K.C. Coplan, and A.A. Jungbluth Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma Am J Surg Pathol 25 2001 197 204
33. S.R. Granter, K.N. Weilbaecher, C. Quigley, C.D. Fletcher, and D.E. Fisher Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma Am J Dermatopathol 23 2001 185 189
34. D. Nonaka, L. Chiriboga, and B.P. Rubin Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors J Cutan Pathol 35 2008 1014 1019
35. T. Nakajima, S. Watanabe, Y. Sato, Y. Shimosato, M. Motoi, and K. Lennert S-100 protein in Langerhans cells, interdigitating reticulum cells and histiocytosis X cells Gann 73 1982 429 432
36. J.M. Coindre, A. de Mascarel, M. Trojani, I. de Mascarel, and A. Pages Immunohistochemical study of rhabdomyosarcoma. Unexpected staining with S100 protein and cytokeratin J Pathol 155 1988 127 132
37. N.G. Ordóñez, S.M. Mahfouz, and B. Mackay Synovial sarcoma: an immunohistochemical and ultrastructural study Hum Pathol 21 1990 733 749
38. N.G. Ordóñez Application of immunocytochemistry in the diagnosis of soft tissue sarcomas: a review and update Adv Anat Pathol 5 1998 67 85
39. M. Miettinen, and K. Franssila Immunohistochemical spectrum of malignant melanoma. The common presence of keratins Lab Invest 61 1989 623 628
40. P.W. Bishop, L.P. Menasce, A.J. Yates, N.A. Win, and S.S. Banerjee An immunophenotypic survey of malignant melanomas Histopathology 23 1993 159 166
41. R. King, K.N. Weilbaecher, G. McGill, E. Cooley, M. Mihm, and D.E. Fisher Microphthalmia transcription factor. A sensitive and specific melanocyte marker for melanoma diagnosis Am J Pathol 155 1999 731 738
42. O. Ben-Izhak, R. Levy, and S. Weill et al. Anorectal malignant melanoma. A clinicopathologic study, including immunohistochemistry and DNA flow cytometry Cancer 79 1997 18 25
43. J.A. Plaza, D. Suster, and D. Perez-Montiel Expression of immunohistochemical markers in primary and metastatic malignant melanoma: a comparative study in 70 patients using a tissue microarray technique Appl Immunohistochem Mol Morphol 15 2007 421 425
44. V.B. Shidham, D. Qi, and R.N. Rao et al. Improved immunohistochemical evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma with 'MCW melanoma cocktail' - a mixture of monoclonal antibodies to MART-1, Melan-A, and tyrosinase BMC Cancer 3 2003 15
45. E.C. Ilg, B.W. Schäfer, and C.W. Heizmann Expression pattern of S100 calcium-binding proteins in human tumors Int J Cancer 68 1996 325 332
46. R. Böni, C.W. Heizmann, and A. Doguoglu et al. Ca(2+)-binding proteins S100A6 and S100B in primary cutaneous melanoma J Cutan Pathol 24 1997 76 80
47. G.M. Maelandsmo, V.A. Flørenes, T. Mellingsaeter, E. Hovig, R.S. Kerbel, and O. Fodstad Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma Int J Cancer 74 1997 464 469
48. A. Ribé, and N.S. McNutt S100A6 protein expression is different in Spitz nevi and melanomas Mod Pathol 16 2003 505 511
49. S. Keijser, G.S. Missotten, J.M. Bonfrer, D. de Wolff-Rouendaal, M.J. Jager, and R.J. de Keizer Immunophenotypic markers to differentiate between benign and malignant melanocytic lesions Br J Ophthalmol 90 2006 213 217
50. A.M. Gown, A.M. Vogel, D. Hoak, F. Gough, and M.A. McNutt Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes Am J Pathol 123 1986 195 203
51. C.E. Bacchi, F. Bonetti, M. Pea, G. Martignoni, and A.M. Gown HMB-45: a review Appl Immunohistochem 4 1996 73 85
52. A.C. Theos, S.T. Truschel, G. Raposo, and M.S. Marks The Silver locus product Pmel17/gp100/Silv/ME20: controversial in name and in function Pigment Cell Res 18 2005 322 336
53. M. Mochii, T. Takeuchi, R. Kodama, K. Agata, and G. Eguchi The expression of melanosomal matrix protein in the transdifferentiation of pigmented epithelial cells into lens cells Cell Differ 23 1988 133 141
54. Z.H. Lee, L. Hou, and G. Moellmann et al. Characterization and subcellular localization of human Pmel 17/silver, a 110-kDa (pre)melanosomal membrane protein associated with 5,6,-dihydroxyindole-2-carboxylic acid (DHICA) converting activity J Invest Dermatol 106 1996 605 610
55. G. Raposo, D. Tenza, D.M. Murphy, J.F. Berson, and M.S. Marks Distinct protein sorting and localization to premelanosomes, melanosomes, and lysosomes in pigmented melanocytic cells J Cell Biol 152 2001 809 824
56. N.R. Dean, J. Brennan, J. Haynes, C. Goddard, and R.D. Cooter Immunohistochemical labeling of normal melanocytes Appl Immunohistochem Mol Morphol 10 2002 199 204
57. N.G. Ordóñez, X.L. Ji, and R.C. Hickey Comparison of HMB-45 monoclonal antibody and S-100 protein in the immunohistochemical diagnosis of melanoma Am J Clin Pathol 90 1988 385 390
58. B.R. Smoller, N.S. McNutt, and A. Hsu HMB-45 staining of dysplastic nevi. Support for a spectrum of progression toward melanoma Am J Surg Pathol 13 1989 680 684
59. I. Ahmed, M. Piepkorn, and D.E. Goldgar et al. HMB-45 staining of dysplastic melanocytic nevi in melanoma risk groups J Cutan Pathol 18 1991 257 260
60. J.D. Harvell, B.C. Bastian, and P.E. LeBoit Persistent (recurrent) Spitz nevi: a histopathologic, immunohistochemical, and molecular pathologic study of 22 cases Am J Surg Pathol 26 2002 654 661
61. H.G. Skelton 3rd, K.J. Smith, T.L. Barrett, G.P. Lupton, and J.H. Graham HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation Am J Dermatopathol 13 1991 543 550
62. W.S. Wood, and V.A. Tron Analysis of HMB-45 immunoreactivity in common and cellular blue nevi J Cutan Pathol 18 1991 261 263
63. V.G. Prieto, and C.R. Shea Use of immunohistochemistry in melanocytic lesions J Cutan Pathol 35 Suppl 2 2008 1 10
64. V.G. Prieto, and C.R. Shea Immunohistochemistry of melanocytic proliferations Arch Pathol Lab Med 135 2011 853 859
65. L.X. Li, K.A. Crotty, S.W. McCarthy, A.A. Palmer, and J.J. Kril A zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions Am J Dermatopathol 22 2000 489 495
66. I.A. Shah, O.S. Gani, and L. Wheler Comparative immunoreactivity of CD-68 and HMB-45 in malignant melanoma, neural tumors and nevi Pathol Res Pract 193 1997 497 502
67. G.E. Orchard Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma Histochem J 32 2000 475 481
68. P. Rochaix, M. Lacroix-Triki, and L. Lamant et al. PNL2, a new monoclonal antibody directed against a fixative-resistant melanocyte antigen Mod Pathol 16 2003 481 490
69. A.S.-Y. Leong, and J. Milios An assessment of a melanoma-specific antibody (HMB-45) and other immunohistochemical markers of malignant melanoma in paraffin embedded tissues Surg Pathol 2 1989 137 145
70. O. Kaufmann, S. Koch, J. Burghardt, H. Audring, and M. Dietel Tyrosinase, melan-A, and KBA62 as markers for the immunohistochemical identification of metastatic amelanotic melanomas on paraffin sections Mod Pathol 11 1998 740 746
71. P.A. Fetsch, F.M. Marincola, A. Filie, Y.M. Hijazi, D.E. Kleiner, and A. Abati Melanoma-associated antigen recognized by T cells (MART-1): the advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration Cancer 87 1999 37 42
72. U. Sundram, J.D. Harvell, R.V. Rouse, and Y. Natkunam Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA Mod Pathol 16 2003 802 810
73. K.J. Busam, D. Kucukgol, E. Sato, D. Frosina, J. Teruya-Feldstein, and A.A. Jungbluth Immunohistochemical analysis of novel monoclonal antibody PNL2 and comparison with other melanocyte differentiation markers Am J Surg Pathol 29 2005 400 406
74. X. Xu, A.Y. Chu, T.L. Pasha, D.E. Elder, and P.J. Zhang Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas Am J Surg Pathol 26 2002 82 87
75. A. Anstey, R. Cerio, N. Ramnarain, G. Orchard, N. Smith, and E.W. Jones Desmoplastic malignant melanoma. An immunocytochemical study of 25 cases Am J Dermatopathol 16 1994 14 22
76. J.A. Carlson, G.R. Dickersin, A.J. Sober, and R.L. Barnhill Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases Cancer 75 1995 478 494
77. V. Winnepenninckx, R. De Vos, M. Stas, and J.J. van den Oord New phenotypical and ultrastructural findings in spindle cell (desmoplastic/ neurotropic) melanoma Appl Immunohistochem Mol Morphol 11 2003 319 325
78. K.J. Busam The use and application of special techniques in assessing melanocytic tumours Pathology 36 2004 462 469
79. P.A. Kay, A.D. Pinheiro, and C.M. Lohse et al. Desmoplastic melanoma of the head and neck: histopathologic and immunohistochemical study of 28 cases Int J Surg Pathol 12 2004 17 24
80. A.K. el-Naggar, N.G. Ordóñez, A. Sara, D. McLemore, and J.G. Batsakis Clear cell sarcomas and metastatic soft tissue melanomas. A flow cytometric comparison and prognostic implications Cancer 67 1991 2173 2179
81. D.R. Lucas, A.G. Nascimento, and F.H. Sim Clear cell sarcoma of soft tissues. Mayo Clinic experience with 35 cases Am J Surg Pathol 16 1992 1197 1204
82. E.S. d'Amore, and V. Ninfo Clear cell tumors of the somatic soft tissues Semin Diagn Pathol 14 1997 270 280
83. S.R. Granter, K.N. Weilbaecher, C. Quigley, C.D. Fletcher, and D.E. Fisher Clear cell sarcoma shows immunoreactivity for microphthalmia transcription factor: further evidence for melanocytic differentiation Mod Pathol 14 2001 6 9
84. H.D. Tazelaar, K.P. Batts, and J.R. Srigley Primary extrapulmonary sugar tumor (PEST): a report of four cases Mod Pathol 14 2001 615 622
85. R. Vang, and R.L. Kempson Perivascular epithelioid cell tumor ('PEComa') of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors Am J Surg Pathol 26 2002 1 13
86. A.L. Folpe, T. Mentzel, H.A. Lehr, C. Fisher, B.L. Balzer, and S.W. Weiss Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature Am J Surg Pathol 29 2005 1558 1575
87. T. Mentzel, S. Reisshauer, A. Rütten, M. Hantschke, L.M. Soares de Almeida, and H. Kutzner Cutaneous clear cell myomelanocytic tumour: a new member of the growing family of perivascular epithelioid cell tumours (PEComas). Clinicopathological and immunohistochemical analysis of seven cases Histopathology 46 2005 498 504
88. M.T. Deavers, A. Malpica, N.G. Ordóñez, and E.G. Silva Ovarian steroid cell tumors: an immunohistochemical study including a comparison of calretinin with inhibin Int J Gynecol Pathol 22 2003 162 167
89. P. Argani, M. Laé, and B. Hutchinson et al. Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR Am J Surg Pathol 29 2005 230 240
90. P.D. Unger, K. Hoffman, S.N. Thung, D. Pertsemlides, D. Wolfe, and M. Kaneko HMB-45 reactivity in adrenal pheochromocytomas Arch Pathol Lab Med 116 1992 151 153
91. M. Fraga, T. García-Caballero, J. Antúnez, M. Couce, A. Beiras, and J. Forteza A comparative immunohistochemical study of phaeochromocytomas and paragangliomas Histol Histopathol 8 1993 429 436
92. S.K. Landas, C. Leigh, S.M. Bonsib, and K. Layne Occurrence of melanin in pheochromocytoma Mod Pathol 6 1993 175 178
93. A.M. Moreno, L. Castilla-Guerra, M.C. Martínez-Torres, F. Torres-Olivera, E. Fernández, and H. Galera-Davidson Expression of neuropeptides and other neuroendocrine markers in human phaeochromocytomas Neuropeptides 33 1999 159 163
94. R. Colombari, F. Bonetti, and G. Zamboni et al. Distribution of melanoma specific antibody (HMB-45) in benign and malignant melanocytic tumours. An immunohistochemical study on paraffin sections Virchows Arch A Pathol Anat Histopathol 413 1988 17 24
95. F. Bonetti, R. Colombari, and E. Manfrin et al. Breast carcinoma with positive results for melanoma marker (HMB-45). HMB-45 immunoreactivity in normal and neoplastic breast Am J Clin Pathol 92 1989 491 495
96. F. Bonetti, M. Pea, and G. Martignoni et al. False-positive immunostaining of normal epithelia and carcinomas with ascites fluid preparations of antimelanoma monoclonal antibody HMB45 Am J Clin Pathol 95 1991 454 459
97. G.J. Adema, A.J. de Boer, and R. van't Hullenaar et al. Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA Am J Pathol 143 1993 1579 1585
98. C. Vennegoor, P. Hageman, and H. Van Nouhuijs et al. A monoclonal antibody specific for cells of the melanocyte lineage Am J Pathol 130 1988 179 192
99. P.J. Ringens, R. van Haperen, and C. Vennegoor et al. Monoclonal antibodies in detection of choroidal melanoma Graefes Arch Clin Exp Ophthalmol 227 1989 287 290
100. Y.T. Chen, E. Stockert, and A. Jungbluth et al. Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas Proc Natl Acad Sci USA 93 1996 5915 5919
101. P.G. Coulie, V. Brichard, and A. Van Pel et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas J Exp Med 180 1994 35 42
102. Y. Kawakami, S. Eliyahu, and C.H. Delgado et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor Proc Natl Acad Sci USA 91 1994 3515 3519
103. Y. Kawakami, S. Eliyahu, and K. Sakaguchi et al. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes J Exp Med 180 1994 347 352
104. Y. Kawakami, J.K. Battles, and T. Kobayashi et al. Production of recombinant MART-1 proteins and specific antiMART-1 polyclonal and monoclonal antibodies: use in the characterization of the human melanoma antigen MART-1 J Immunol Methods 202 1997 13 25
105. S. Reinke, P. Koniger, and G. Herberth et al. Differential expression of MART-1, tyrosinase, and SM5-1 in primary and metastatic melanoma Am J Dermatopathol 27 2005 401 406
106. J. Zubovits, E. Buzney, L. Yu, and L.M. Duncan HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma Hum Pathol 35 2004 217 223
107. H. Zhang, H. Bu, and H. Chen et al. Comparison of immunohistochemical markers in the differential diagnosis of adrenocortical tumors: immunohistochemical analysis of adrenocortical tumors Appl Immunohistochem Mol Morphol 16 2008 32 39
108. A.A. Jungbluth, K.J. Busam, and W.L. Gerald et al. A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues Am J Surg Pathol 22 1998 595 602
109. K.S. Clarkson, I.C. Sturdgess, and A.J. Molyneux The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A) J Clin Pathol 54 2001 196 200
110. G. Orchard Evaluation of melanocytic neoplasms: application of a pan-melanoma antibody cocktail Br J Biomed Sci 59 2002 196 202
111. T.S. Loy, R.W. Phillips, and C.L. Linder A103 immunostaining in the diagnosis of adrenal cortical tumors: an immunohistochemical study of 316 cases Arch Pathol Lab Med 126 2002 170 172
112. Z. Ghorab, M. Jorda, P. Ganjei, and M. Nadji Melan A (A103) is expressed in adrenocortical neoplasms but not in renal cell and hepatocellular carcinomas Appl Immunohistochem Mol Morphol 11 2003 330 333
113. C.C. Pan, P.C. Chen, S.H. Tsay, and D.M. Ho Differential immunoprofiles of hepatocellular carcinoma, renal cell carcinoma, and adrenocortical carcinoma: a systemic immunohistochemical survey using tissue array technique Appl Immunohistochem Mol Morphol 13 2005 347 352
114. C.J. Stewart, C.L. Nandini, and J.A. Richmond Value of A103 (melan-A) immunostaining in the differential diagnosis of ovarian sex cord stromal tumours J Clin Pathol 53 2000 206 211
115. C. Zhao, T.N. Vinh, K. McManus, D. Dabbs, R. Barner, and R. Vang Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors Am J Surg Pathol 33 2009 354 366
116. K. Busam, and A. Jungbluth The new melanoma markers: MART-1 and Melan-A (The NIH experience) (letter) Am J Surg Pathol 23 1999 610
117. P.A. Fetsch, F.M. Marincola, and A. Abati The new melanoma markers: MART-1 and Melan-A (the NIH experience) Am J Surg Pathol 23 1999 607 610
118. M. Zenali, M.T. Deavers, N. Kalhor, and V.G. Prieto Malignant mesothelioma expresses melan-A (A-103), a possible diagnostic pitfall Mod Pathol 24 Suppl 1 2011 A429
119. N.G. Ordóñez, S.S. Shen, M. Zenali, and M.T. Deavers Melan A (A103) is not a marker of mesothelioma Appl Immunohistochem Mol Morphol 21 2003 181 184
120. J.L. Hornick, and C.D. Fletcher PEComa: what do we know so far? Histopathology 48 2006 75 82
121. K.T. Mai, and E.C. Belanger Perivascular epithelioid cell tumour (PEComa) of the soft tissue Pathology 38 2006 415 420
122. D.C. Dim, L.D. Cooley, and R.N. Miranda Clear cell sarcoma of tendons and aponeuroses: a review Arch Pathol Lab Med 131 2007 152 156
123. A.M. Korner, and J.M. Pawelek Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin Science 217 1982 1163 1165
124. J.M. Pawelek After dopachrome? Pigment Cell Res 4 1991 53 62
125. W.S. Oetting, and R.A. King Molecular basis of albinism: mutations and polymorphisms of pigmentation genes associated with albinism Hum Mutat 13 1999 99 115
126. A.A. Jungbluth, K. Iversen, and K. Coplan et al. T311-an anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues Pathol Res Pract 196 2000 235 242
127. G.F. Hofbauer, J. Kamarashev, R. Geertsen, R. Boni, and R. Dummer Tyrosinase immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution J Cutan Pathol 25 1998 204 209
128. P.A. Fetsch, A.I. Riker, F.M. Marincola, and A. Abati Tyrosinase immunoreactivity in fine-needle aspiration samples of metastatic malignant melanoma Cancer 90 2000 252 257
129. A.A. Jungbluth, R. King, and D.E. Fisher et al. Immunohistochemical and reverse transcription-polymerase chain reaction expression analysis of tyrosinase and microphthalmia-associated transcription factor in angiomyolipomas Appl Immunohistochem Mol Morphol 9 2001 29 34
130. C.H. Stone, M.W. Lee, and M.B. Amin et al. Renal angiomyolipoma: Further immunophenotypic characterization of an expanding morphologic spectrum Arch Pathol Lab Med 125 2001 751 758
131. A. Zavala-Pompa, A.L. Folpe, and R.E. Jimenez et al. Immunohistochemical study of microphthalmia transcription factor and tyrosinase in angiomyolipoma of the kidney, renal cell carcinoma, and renal and retroperitoneal sarcomas: comparative evaluation with traditional diagnostic markers Am J Surg Pathol 25 2001 65 70
132. H.R. Makhlouf, K.G. Ishak, R. Shekar, I.A. Sesterhenn, D.Y. Young, and J.C. Fanburg-Smith Melanoma markers in angiomyolipoma of the liver and kidney. A comparative study Arch Pathol Lab Med 126 2002 49 55
133. L.G. Morris, Y.H. Wen, and D. Nonaka et al. PNL2 melanocytic marker in immunohistochemical evaluation of primary mucosal melanoma of the head and neck Head Neck 30 2008 771 775
134. P.P. Aung, M. Sarlomo-Rikala, J. Lasota, J.P. Lai, Z.F. Wang, and M. Miettinen KBA62 and PNL2: 2 new melanoma markers-immunohistochemical analysis of 1563 tumors including metastatic, desmoplastic, and mucosal melanomas and their mimics Am J Surg Pathol 36 2012 265 272
135. E. Steingrímsson, N.G. Copeland, and N.A. Jenkins Melanocytes and the microphthalmia transcription factor network Annu Rev Genet 38 2004 365 411
136. C. Levy, M. Khaled, and D.E. Fisher MITF: master regulator of melanocyte development and melanoma oncogene Trends Mol Med 12 2006 406 414
137. N. Fuse, K. Yasumoto, H. Suzuki, K. Takahashi, and S. Shibahara Identification of a melanocyte-type promoter of the microphthalmia-associated transcription factor gene Biochem Biophys Res Commun 219 1996 702 707
138. R. King, P.B. Googe, K.N. Weilbaecher, M.C. Mihm Jr., and D.E. Fisher Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors Am J Surg Pathol 25 2001 51 57
139. C.C. Dorvault, K.N. Weilbaecher, and H. Yee et al. Microphthalmia transcription factor: a sensitive and specific marker for malignant melanoma in cytologic specimens Cancer 93 2001 337 343
140. F.M. O'Reilly, D.J. Brat, B.E. McAlpine, H.E. Grossniklaus, A.L. Folpe, and J.L. Arbiser Microphthalmia transcription factor immunohistochemistry: a useful diagnostic marker in the diagnosis and detection of cutaneous melanoma, sentinel lymph node metastases, and extracutaneous melanocytic neoplasms J Am Acad Dermatol 45 2001 414 419
141. S. Iwamoto, R.C. Burrows, and R.E. Kalina et al. Immunophenotypic differences between uveal and cutaneous melanomas Arch Ophthalmol 120 2002 466 470
142. M.V. Sheffield, H. Yee, and C.C. Dorvault et al. Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations Am J Clin Pathol 118 2002 930 936
143. M.B. Koch, I.M. Shih, S.W. Weiss, and A.L. Folpe Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics Am J Surg Pathol 25 2001 58 64
144. M. Hisaoka, T. Ishida, and T.T. Kuo et al. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases Am J Surg Pathol 32 2008 452 460
145. E. Cohen-Knafo, T. al Saati, and J. Aziza et al. Production and characterisation of an antimelanoma monoclonal antibody KBA.62 using a new melanoma cell line reactive on paraffin wax embedded sections J Clin Pathol 48 1995 826 831
146. C. Pagès, P. Rochaix, and T. al Saati et al. KBA.62: a useful marker for primary and metastatic melanomas Hum Pathol 39 2008 1136 1142
147. A. Grossman, H.W. Mittrücker, and J. Nicholl et al. Cloning of human lymphocyte-specific interferon regulatory factor (hLSIRF/hIRF4) and mapping of the gene to 6p23-p25 Genomics 37 1996 229 233
148. B. Falini, M. Fizzotti, and A. Pucciarini et al. A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells Blood 95 2000 2084 2092
149. Y. Natkunam, R.A. Warnke, K. Montgomery, B. Falini, and M. van De Rijn Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry Mod Pathol 14 2001 686 694
150. K. Ferenczi, R.R. Lastra, and T. Farkas et al. MUM-1 expression differentiates tumors in the PEComa family from clear cell sarcoma and melanoma Int J Surg Pathol 20 2012 29 36
151. S.B. Potterf, R. Mollaaghababa, and L. Hou et al. Analysis of SOX10 function in neural crest-derived melanocyte development: SOX10-dependent transcriptional control of dopachrome tautomerase Dev Biol 237 2001 245 257
152. R.N. Kelsh Sorting out Sox10 functions in neural crest development Bioessays 28 2006 788 798
153. E. Blochin, and D. Nonaka Diagnostic value of Sox10 immunohistochemical staining for the detection of metastatic melanoma in sentinel lymph nodes Histopathology 55 2009 626 628
154. T.R. Gershon, O. Oppenheimer, S.S. Chin, and W.L. Gerald Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation Neoplasia 7 2005 575 584
155. M. Agnarsdóttir, L. Sooman, and A. Bolander et al. SOX10 expression in superficial spreading and nodular malignant melanomas Melanoma Res 20 2010 468 478
156. F.I. Ramos-Herberth, J. Karamchandani, J. Kim, and S.S. Dadras SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar J Cutan Pathol 37 2010 944 952
157. C. Jennings, and J. Kim Identification of nodal metastases in melanoma using sox-10 Am J Dermatopathol 33 2011 474 482
158. J.R. Karamchandani, T.O. Nielsen, M. van de Rijn, and R.B. West Sox10 and S100 in the diagnosis of soft-tissue neoplasms Appl Immunohistochem Mol Morphol 20 2012 445 450
159. J.C. García-Borrón, B.L. Sánchez-Laorden, and C. Jiménez-Cervantes Melanocortin-1 receptor structure and functional regulation Pigment Cell Res 18 2005 393 410
160. F. Salazar-Onfray, M. López, and A. Lundqvist et al. Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker Br J Cancer 87 2002 414 422
161. M.N. López, C. Pereda, and M. Ramírez et al. Melanocortin 1 receptor is expressed by uveal malignant melanoma and can be considered a new target for diagnosis and immunotherapy Invest Ophthalmol Vis Sci 48 2007 1219 1227
162. I.M. Shih, M. Nesbit, M. Herlyn, and R.J. Kurman A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue Mod Pathol 11 1998 1098 1106
163. C. Vennegoor, J. Calafat, and P. Hageman et al. Biochemical characterization and cellular localization of a formalin-resistant melanoma-associated antigen reacting with monoclonal antibody NKI/C-3 Int J Cancer 35 1985 287 295
164. S. Ramachandra, C.E. Gillett, and R.R. Millis A comparative immunohistochemical study of mammary and extramammary Paget's disease and superficial spreading melanoma, with particular emphasis on melanocytic markers Virchows Arch 429 1996 371 376
165. R. Sachdev, and U.N. Sundram Frequent positive staining with NKI/C3 in normal and neoplastic tissues limits its usefulness in the diagnosis of cellular neurothekeoma Am J Clin Pathol 126 2006 554 563
166. J.N. Eble, M.B. Amin, and R.H. Young Epithelioid angiomyolipoma of the kidney: a report of five cases with a prominent and diagnostically confusing epithelioid smooth muscle component Am J Surg Pathol 21 1997 1123 1130
167. M.J. Gaffey, S.E. Mills, R.J. Zarbo, L.M. Weiss, and A.M. Gown Clear cell tumor of the lung. Immunohistochemical and ultrastructural evidence of melanogenesis Am J Surg Pathol 15 1991 644 653
168. C.K. Ma, R.J. Zarbo, and A.M. Gown Immunohistochemical characterization of atypical fibroxanthoma and dermatofibrosarcoma protuberans Am J Clin Pathol 97 1992 478 483
169. E. Calonje, E. Wilson-Jones, N.P. Smith, and C.D. Fletcher Cellular 'neurothekeoma': an epithelioid variant of pilar leiomyoma? Morphological and immunohistochemical analysis of a series Histopathology 20 1992 397 404
170. K.J. Busam, T. Mentzel, C. Colpaert, R.L. Barnhill, and C.D. Fletcher Atypical or worrisome features in cellular neurothekeoma: a study of 10 cases Am J Surg Pathol 22 1998 1067 1072
171. R.N. Page, R. King, M.C. Mihm Jr., and P.B. Googe Microphthalmia transcription factor and NKI/C3 expression in cellular neurothekeoma Mod Pathol 17 2004 230 234
172. A.J.F. Lazar, and C.D.M. Fletcher Primitive nonneural granular cell tumors of skin: clinicopathologic analysis of 13 cases Am J Surg Pathol 29 2005 927 934
173. C. Monteagudo, L. Calduch, S. Navarro, A. Joan-Figueroa, and A. Llombart-Bosch CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value Am J Clin Pathol 117 2002 126 131
174. O. Mete, I. Kilicaslan, M.G. Gulluoglu, and V. Uysal Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis Virchows Arch 447 2005 938 946
175. P.G. Chesa, W.J. Rettig, T.M. Thomson, L.J. Old, and M.R. Melamed Immunohistochemical analysis of nerve growth factor receptor expression in normal and malignant human tissues J Histochem Cytochem 36 1988 383 389
176. J.C. Fanburg-Smith, and M. Miettinen Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other nonneural tumors: a study of 1,150 tumors and fetal and adult normal tissues Hum Pathol 32 2001 976 983
177. A.H. Ross, P. Grob, and M. Bothwell et al. Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies Proc Natl Acad Sci USA 81 1984 6681 6685
178. R. Lazova, I. Tantcheva-Poor, and A.C. Sigal P75 nerve growth factor receptor staining is superior to S100 in identifying spindle cell and desmoplastic melanoma J Am Acad Dermatol 63 2010 852 858
179. J.A. Reed, B. Finnerty, and A.P. Albino Divergent cellular differentiation pathways during the invasive stage of cutaneous malignant melanoma progression Am J Pathol 155 1999 549 555
180. S. Iwamoto, R.C. Burrows, S.N. Agoff, M. Piepkorn, M. Bothwell, and R. Schmidt The p75 neurotrophin receptor, relative to other Schwann cell and melanoma markers, is abundantly expressed in spindled melanomas Am J Dermatopathol 23 2001 288 294
181. A. Radfar, C.M. Stefanato, S. Ghosn, and J. Bhawan NGFR-positive desmoplastic melanomas with focal or absent S-100 staining: further evidence supporting the use of both NGFR and S-100 as a primary immunohistochemical panel for the diagnosis of desmoplastic melanomas Am J Dermatopathol 28 2006 162 167